Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1988 Oct;1(4):365–376. doi: 10.1128/cmr.1.4.365

Pertussis: the disease and new diagnostic methods.

R L Friedman 1
PMCID: PMC358060  PMID: 2906814

Abstract

Bordetella pertussis, the causative agent of whooping cough, produces an acute and chronic respiratory infection in infants and young children. B. pertussis is still a major health problem of young children throughout the world even though effective immunization against whooping cough is available. While predominantly a childhood disease, it has been reported also to be a cause of persistent cough in adults. This review discusses the numerous bacterial virulence factors that may play roles in the pathogenesis of pertussis and in immunity to infection. The present problems with pertussis diagnosis, recent advances, and future prospects for new and improved rapid diagnostics tests also are explored.

Full text

PDF
365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aftandelians R., Connor J. D. Bactericidal antibody in serum during infection with Bordetalla pertussis. J Infect Dis. 1973 Oct;128(4):555–558. doi: 10.1093/infdis/128.4.555. [DOI] [PubMed] [Google Scholar]
  2. Ahluwalia G., Embree J., McNicol P., Law B., Hammond G. W. Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol. 1987 May;25(5):763–767. doi: 10.1128/jcm.25.5.763-767.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aoyama T., Murase Y., Iwata T., Imaizumi A., Suzuki Y., Sato Y. Comparison of blood-free medium (cyclodextrin solid medium) with Bordet-Gengou medium for clinical isolation of Bordetella pertussis. J Clin Microbiol. 1986 Jun;23(6):1046–1048. doi: 10.1128/jcm.23.6.1046-1048.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arai H., Sato Y. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochim Biophys Acta. 1976 Oct 22;444(3):765–782. doi: 10.1016/0304-4165(76)90323-8. [DOI] [PubMed] [Google Scholar]
  5. Arciniega J. L., Burns D. L., Garcia-Ortigoza E., Manclark C. R. Immune response to the B oligomer of pertussis toxin. Infect Immun. 1987 May;55(5):1132–1136. doi: 10.1128/iai.55.5.1132-1136.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ashworth L. A., Irons L. I., Dowsett A. B. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun. 1982 Sep;37(3):1278–1281. doi: 10.1128/iai.37.3.1278-1281.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ayme G., Caroff M., Chaby R., Haeffner-Cavaillon N., Le Dur A., Moreau M., Muset M., Mynard M. C., Roumiantzeff M., Schulz D. Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect Immun. 1980 Mar;27(3):739–745. doi: 10.1128/iai.27.3.739-745.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Badr-El-Din M. K., Aref G. H., Mazloum H., El-Towesy Y. A., Kassem A. S., Abdel-Moneim M. A., Abbassy A. A. The beta-adrenergic receptors in pertussis. J Trop Med Hyg. 1976 Oct;79(10):213–217. [PubMed] [Google Scholar]
  9. Baraff L. J., Wilkins J., Wehrle P. F. The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics. 1978 Feb;61(2):224–230. [PubMed] [Google Scholar]
  10. Bass J. W., Klenk E. L., Kotheimer J. B., Linnemann C. C., Smith M. H. Antimicrobial treatment of pertussis. J Pediatr. 1969 Nov;75(5):768–781. doi: 10.1016/s0022-3476(69)80299-4. [DOI] [PubMed] [Google Scholar]
  11. Belmaaza A., Hamel J., Mousseau S., Montplaisir S., Brodeur B. R. Rapid diagnosis of severe Haemophilus influenzae serotype b infections by monoclonal antibody enzyme immunoassay for outer membrane proteins. J Clin Microbiol. 1986 Sep;24(3):440–445. doi: 10.1128/jcm.24.3.440-445.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Benson R. F., Thacker W. L., Plikaytis B. B., Wilkinson H. W. Cross-reactions in Legionella antisera with Bordetella pertussis strains. J Clin Microbiol. 1987 Apr;25(4):594–596. doi: 10.1128/jcm.25.4.594-596.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Boreland P. C., Gillespie S. H. Counterimmunoelectrophoresis in the diagnosis of whooping cough. J Clin Pathol. 1984 Aug;37(8):950–951. doi: 10.1136/jcp.37.8.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  15. Bradstreet C. M., Tannahill A. J., Edwards J. M., Benson P. F. Detection of Bordetella pertussis antibodies in human sera by complement-fixation and immunofluorescence. J Hyg (Lond) 1972 Mar;70(1):75–83. doi: 10.1017/s0022172400022117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bromberg K., Tannis G., Daidone B., Clarke L., Sierra M. F. Comparison of ortho respiratory syncytial virus enzyme-linked immunosorbent assay and HEp-2 cell culture. J Clin Microbiol. 1985 Dec;22(6):1071–1072. doi: 10.1128/jcm.22.6.1071-1072.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Brown D. R., Parker C. D. Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infect Immun. 1987 Jan;55(1):154–161. doi: 10.1128/iai.55.1.154-161.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Burstyn D. G., Baraff L. J., Peppler M. S., Leake R. D., St Geme J., Jr, Manclark C. R. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun. 1983 Sep;41(3):1150–1156. doi: 10.1128/iai.41.3.1150-1156.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cavalieri S. J., Bohach G. A., Snyder I. S. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol Rev. 1984 Dec;48(4):326–343. doi: 10.1128/mr.48.4.326-343.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chalvardjian N. The laboratory diagnosis of whooping cough by fluorescent antibody and by culture methods. Can Med Assoc J. 1966 Aug 6;95(6):263–266. [PMC free article] [PubMed] [Google Scholar]
  21. Chao R. K., Fishaut M., Schwartzman J. D., McIntosh K. Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis. 1979 Apr;139(4):483–486. doi: 10.1093/infdis/139.4.483. [DOI] [PubMed] [Google Scholar]
  22. Cherry J. D. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984 Feb;14(2):1–78. doi: 10.1016/0045-9380(84)90016-1. [DOI] [PubMed] [Google Scholar]
  23. Cody C. L., Baraff L. J., Cherry J. D., Marcy S. M., Manclark C. R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981 Nov;68(5):650–660. [PubMed] [Google Scholar]
  24. Cone T. C., Jr Whooping cough is first described as a disease sui generis by Baillou in 1640. Pediatrics. 1970 Oct;46(4):522–522. [PubMed] [Google Scholar]
  25. Confer D. L., Eaton J. W. Bordetella adenylate cyclase: host toxicity and diagnostic utility. Dev Biol Stand. 1985;61:3–10. [PubMed] [Google Scholar]
  26. Confer D. L., Eaton J. W. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 1982 Sep 3;217(4563):948–950. doi: 10.1126/science.6287574. [DOI] [PubMed] [Google Scholar]
  27. Cooperstock M., Riegle L. Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria. Infect Immun. 1981 Jul;33(1):315–318. doi: 10.1128/iai.33.1.315-318.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Cowell J. L., Hewlett E. L., Manclark C. R. Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun. 1979 Sep;25(3):896–901. doi: 10.1128/iai.25.3.896-901.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Cowell J. L., Zhang J. M., Urisu A., Suzuki A., Steven A. C., Liu T., Liu T. Y., Manclark C. R. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun. 1987 Apr;55(4):916–922. doi: 10.1128/iai.55.4.916-922.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Crosson F. J., Jr, Winkelstein J. A., Moxon E. R. Enzyme-linked immunosorbent assay for detection and quantitation of capsular antigen of Haemophilus influenzae type b. Infect Immun. 1978 Nov;22(2):617–619. doi: 10.1128/iai.22.2.617-619.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Diagnosis of whooping cough: comparison of serological tests with isolation of Bordetella pertussis. A combined Scottish study. Br Med J. 1970 Dec 12;4(5736):637–639. [PMC free article] [PubMed] [Google Scholar]
  32. Dolby J. M., Stephens S. Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J Hyg (Lond) 1973 Mar;71(1):193–207. doi: 10.1017/s0022172400046362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. ELDERING G., HORNBECK C., BAKER J. Serological study of Bordetella pertussis and related species. J Bacteriol. 1957 Aug;74(2):133–136. doi: 10.1128/jb.74.2.133-136.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Eisenstein B. I., Engleberg N. C. Applied molecular genetics: new tools for microbiologists and clinicians. J Infect Dis. 1986 Mar;153(3):416–430. doi: 10.1093/infdis/153.3.416. [DOI] [PubMed] [Google Scholar]
  35. Eldering G., Holwerda J., Davis A., Baker J. Bordetella pertussis serotypes in the United States. Appl Microbiol. 1969 Oct;18(4):618–621. doi: 10.1128/am.18.4.618-621.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. FELTON H. M. Pertussis; current status of prevention and treatment. Pediatr Clin North Am. 1957 Feb;:271–283. doi: 10.1016/s0031-3955(16)30486-2. [DOI] [PubMed] [Google Scholar]
  37. Friedman E., Farfel Z., Hanski E. The invasive adenylate cyclase of Bordetella pertussis. Properties and penetration kinetics. Biochem J. 1987 Apr 1;243(1):145–151. doi: 10.1042/bj2430145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Friedman R. L. Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography. Infect Immun. 1987 Jan;55(1):129–134. doi: 10.1128/iai.55.1.129-134.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Friedman R. L., Fiederlein R. L., Glasser L., Galgiani J. N. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect Immun. 1987 Jan;55(1):135–140. doi: 10.1128/iai.55.1.135-140.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gilligan P. H., Fisher M. C. Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol. 1984 Nov;20(5):891–893. doi: 10.1128/jcm.20.5.891-893.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gilman A. G. G proteins and dual control of adenylate cyclase. Cell. 1984 Mar;36(3):577–579. doi: 10.1016/0092-8674(84)90336-2. [DOI] [PubMed] [Google Scholar]
  42. Goldman W. E., Baseman J. B. Selective isolation and culture of a proliferating epithelial cell population from the hamster trachea. In Vitro. 1980 Apr;16(4):313–319. doi: 10.1007/BF02618337. [DOI] [PubMed] [Google Scholar]
  43. Goldman W. E., Herwaldt L. A. Bordetella pertussis tracheal cytotoxin. Dev Biol Stand. 1985;61:103–111. [PubMed] [Google Scholar]
  44. Goldman W. E., Klapper D. G., Baseman J. B. Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun. 1982 May;36(2):782–794. doi: 10.1128/iai.36.2.782-794.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Goodman Y. E., Wort A. J., Jackson F. L. Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J Clin Microbiol. 1981 Feb;13(2):286–292. doi: 10.1128/jcm.13.2.286-292.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Goodnow R. A. Biology of Bordetella bronchiseptica. Microbiol Rev. 1980 Dec;44(4):722–738. doi: 10.1128/mr.44.4.722-738.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Granström M., Granström G., Gillenius P., Askelöf P. Neutralizing antibodies to pertussis toxin in whooping cough. J Infect Dis. 1985 Apr;151(4):646–649. doi: 10.1093/infdis/151.4.646. [DOI] [PubMed] [Google Scholar]
  48. Granström M., Granström G., Lindfors A., Askelöf P. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J Infect Dis. 1982 Dec;146(6):741–745. doi: 10.1093/infdis/146.6.741. [DOI] [PubMed] [Google Scholar]
  49. Granström M., Lindberg A. A., Askelöf P., Hederstedt B. Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J Med Microbiol. 1982 Feb;15(1):85–96. doi: 10.1099/00222615-15-1-85. [DOI] [PubMed] [Google Scholar]
  50. HOLWERDA J., ELDERING G. CULTURE AND FLUORESCENT-ANTIBODY METHODS IN DIAGNOSIS OF WHOOPING COUGH. J Bacteriol. 1963 Sep;86:449–451. doi: 10.1128/jb.86.3.449-451.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Haeffner N., Chaby R., Szabó L. Identification of 2-methyl-3-hydroxydecanoic and 2-methyl-3-hydroxytetradecanoic acids in the 'lipid X' fraction of the Bordetella pertussis endotoxin. Eur J Biochem. 1977 Aug 1;77(3):535–544. doi: 10.1111/j.1432-1033.1977.tb11696.x. [DOI] [PubMed] [Google Scholar]
  52. Hanski E., Farfel Z. Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J Biol Chem. 1985 May 10;260(9):5526–5532. [PubMed] [Google Scholar]
  53. Hendry R. M., Pierik L. T., McIntosh K. Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986 Feb;23(2):383–384. doi: 10.1128/jcm.23.2.383-384.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Hewlett E. L. Selective primary health care: strategies for control of disease in the developing world. XVII. Pertussis and diphtheria. Rev Infect Dis. 1985 May-Jun;7(3):426–433. doi: 10.1093/clinids/7.3.426. [DOI] [PubMed] [Google Scholar]
  55. Hewlett E. L., Urban M. A., Manclark C. R., Wolff J. Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A. 1976 Jun;73(6):1926–1930. doi: 10.1073/pnas.73.6.1926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hewlett E. L., Weiss A. A., Crane J. K., Pearson R. D., Anderson H. J., Myers G. A., Evans W. S., Hantske L. L., Kay H. D., Cronin M. J. Bordetella extracytoplasmic adenylate cyclase: actions as a bacterial toxin. Dev Biol Stand. 1985;61:21–26. [PubMed] [Google Scholar]
  57. Hewlett E., Wolff J. Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization. J Bacteriol. 1976 Aug;127(2):890–898. doi: 10.1128/jb.127.2.890-898.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Hill H. R., Matsen J. M. Enzyme-linked immunosorbent assay and radioimmunoassay in the serologic diagnosis of infectious diseases. J Infect Dis. 1983 Feb;147(2):258–263. doi: 10.1093/infdis/147.2.258. [DOI] [PubMed] [Google Scholar]
  59. Hoppe J. E., Vogl R. Comparison of three media for culture of Bordetella pertussis. Eur J Clin Microbiol. 1986 Jun;5(3):361–363. doi: 10.1007/BF02017801. [DOI] [PubMed] [Google Scholar]
  60. Hoppe J. E., Wörz S., Botzenhart K. Comparison of specimen transport systems for Bordetella pertussis. Eur J Clin Microbiol. 1986 Dec;5(6):671–673. doi: 10.1007/BF02013299. [DOI] [PubMed] [Google Scholar]
  61. Hornsleth A., Friis B., Krasilnikof P. A. Detection of respiratory syncytial virus in nasopharyngeal secretions by a biotin-avidin ELISA more sensitive than the fluorescent antibody technique. J Med Virol. 1986 Feb;18(2):113–117. doi: 10.1002/jmv.1890180203. [DOI] [PubMed] [Google Scholar]
  62. Hunter P. R. Survival of Bordetella pertussis in transport media. J Clin Pathol. 1986 Jan;39(1):119–120. doi: 10.1136/jcp.39.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Håkansson S., Sundin C. G., Granström M., Gästrin B. Diagnosis of whooping cough--a comparison of culture, immunofluorescence and serology with ELISA. Scand J Infect Dis. 1984;16(3):281–284. doi: 10.3109/00365548409070401. [DOI] [PubMed] [Google Scholar]
  64. Imaizumi A., Suzuki Y., Ono S., Sato H., Sato Y. Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I. J Clin Microbiol. 1983 May;17(5):781–786. doi: 10.1128/jcm.17.5.781-786.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Irons L. I., Ashworth L. A., Wilton-Smith P. Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies. J Gen Microbiol. 1983 Sep;129(9):2769–2778. doi: 10.1099/00221287-129-9-2769. [DOI] [PubMed] [Google Scholar]
  66. Jones G. L., Kendrick P. L. Study of a blood-free medium for transport and growth of Bordetella pertussis. Health Lab Sci. 1969 Jan;6(1):40–45. [PubMed] [Google Scholar]
  67. Katada T., Ui M. ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem. 1982 Jun 25;257(12):7210–7216. [PubMed] [Google Scholar]
  68. Kawai Y., Moribayashi A., Yano I. Ornithine-containing lipid of Bordetella pertussis that carries hemagglutinating activity. J Bacteriol. 1982 Nov;152(2):907–910. doi: 10.1128/jb.152.2.907-910.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kessin R. H., Franke J. Secreted adenylate cyclase of Bordetella pertussis: calmodulin requirements and partial purification of two forms. J Bacteriol. 1986 Apr;166(1):290–296. doi: 10.1128/jb.166.1.290-296.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. LAMBERT H. J. EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN. Public Health Rep. 1965 Apr;80:365–369. [PMC free article] [PubMed] [Google Scholar]
  71. Ladant D., Brezin C., Alonso J. M., Crenon I., Guiso N. Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay. J Biol Chem. 1986 Dec 5;261(34):16264–16269. [PubMed] [Google Scholar]
  72. Laurance B. M. Chronic pulmonary infection in childhood. Practitioner. 1965 Dec;195(170):749–754. [PubMed] [Google Scholar]
  73. Lawrence A. J., Paton J. C. Efficacy of enzyme-linked immunosorbent assay for rapid diagnosis of Bordetella pertussis infection. J Clin Microbiol. 1987 Nov;25(11):2102–2104. doi: 10.1128/jcm.25.11.2102-2104.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Le Dur A., Chaby R., Szabó L. Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin. J Bacteriol. 1980 Jul;143(1):78–88. doi: 10.1128/jb.143.1.78-88.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Leary J. J., Brigati D. J., Ward D. C. Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4045–4049. doi: 10.1073/pnas.80.13.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Leppla S. H. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A. 1982 May;79(10):3162–3166. doi: 10.1073/pnas.79.10.3162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Lewis F. A., Gust I. D., Bennett N. M. On the aetiology of whooping cough. J Hyg (Lond) 1973 Mar;71(1):139–144. doi: 10.1017/s0022172400046301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Linnemann C. C., Jr, Nasenbeny J. Pertussis in the adult. Annu Rev Med. 1977;28:179–185. doi: 10.1146/annurev.me.28.020177.001143. [DOI] [PubMed] [Google Scholar]
  79. Linnemann C. C., Jr, Partin J. C., Perlstein P. H., Englender G. S. Pertussis: persistent problems. J Pediatr. 1974 Oct;85(4):589–591. doi: 10.1016/s0022-3476(74)80496-8. [DOI] [PubMed] [Google Scholar]
  80. Livey I., Wardlaw A. C. Production and properties of Bordetella pertussis heat-labile toxin. J Med Microbiol. 1984 Feb;17(1):91–103. doi: 10.1099/00222615-17-1-91. [DOI] [PubMed] [Google Scholar]
  81. Locht C., Keith J. M. Pertussis toxin gene: nucleotide sequence and genetic organization. Science. 1986 Jun 6;232(4755):1258–1264. doi: 10.1126/science.3704651. [DOI] [PubMed] [Google Scholar]
  82. MISHULOW L., SHARPE L. S., COHEN L. L. Beef-heart charcoal agar for the preparation of pertussis vaccines. Am J Public Health Nations Health. 1953 Nov;43(11):1466–1472. doi: 10.2105/ajph.43.11.1466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. MUNOZ J., RIBI E., LARSON C. L. Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm. J Immunol. 1959 Nov;83:496–501. [PubMed] [Google Scholar]
  84. Macaulay M. E. The IgM and IgG response to Bordetella pertussis vaccination and infection. J Med Microbiol. 1981 Feb;14(1):1–7. doi: 10.1099/00222615-14-1-1. [DOI] [PubMed] [Google Scholar]
  85. Mahieu J. M., Muller A. S., Voorhoeve A. M., Dikken H. Pertussis in a rural area of Kenya: epidemiology and a preliminary report on a vaccine trial. Bull World Health Organ. 1978;56(5):773–780. [PMC free article] [PubMed] [Google Scholar]
  86. Marchitto K. S., Smith S. G., Locht C., Keith J. M. Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun. 1987 Mar;55(3):497–501. doi: 10.1128/iai.55.3.497-501.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Masure H. R., Shattuck R. L., Storm D. R. Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases. Microbiol Rev. 1987 Mar;51(1):60–65. doi: 10.1128/mr.51.1.60-65.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. McIntosh K., Hendry R. M., Fahnestock M. L., Pierik L. T. Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol. 1982 Aug;16(2):329–333. doi: 10.1128/jcm.16.2.329-333.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Melly M. A., McGee Z. A., Rosenthal R. S. Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis. 1984 Mar;149(3):378–386. doi: 10.1093/infdis/149.3.378. [DOI] [PubMed] [Google Scholar]
  90. Mertsola J., Kuronen T., Turunen A., Viljanen M. K., Ruuskanen O. Diagnosis of pertussis. J Infect. 1984 Mar;8(2):149–156. doi: 10.1016/s0163-4453(84)92559-3. [DOI] [PubMed] [Google Scholar]
  91. Mertsola J., Ruuskanen O., Kuronen T., Viljanen M. K. Serologic diagnosis of pertussis: comparison of enzyme-linked immunosorbent assay and bacterial agglutination. J Infect Dis. 1983 Feb;147(2):252–257. doi: 10.1093/infdis/147.2.252. [DOI] [PubMed] [Google Scholar]
  92. Miller D. L., Ross E. M., Alderslade R., Bellman M. H., Rawson N. S. Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) 1981 May 16;282(6276):1595–1599. doi: 10.1136/bmj.282.6276.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Moreau M., Chaby R., Szabo L. Structure of the terminal reducing heptasaccharide of polysaccharide 1 isolated from the Bordetella pertussis endotoxin. J Bacteriol. 1984 Aug;159(2):611–617. doi: 10.1128/jb.159.2.611-617.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Morse S. I., Morse J. H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med. 1976 Jun 1;143(6):1483–1502. doi: 10.1084/jem.143.6.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Munoz J. J., Bergman R. K., Robbins K. E. Comparison of the histamine hypersensitivity and the Limulus amoebocyte lysate tests for endotoxin activity. Infect Immun. 1978 Oct;22(1):292–294. doi: 10.1128/iai.22.1.292-294.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Nagel J., Poot-Scholtens E. J. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol. 1983 Nov;16(4):417–426. doi: 10.1099/00222615-16-4-417. [DOI] [PubMed] [Google Scholar]
  97. Nakase Y., Endoh M. Bordetella heat-labile toxin: further purification, characterization and mode of action. Dev Biol Stand. 1985;61:93–102. [PubMed] [Google Scholar]
  98. Nelson J. D. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child. 1978 Apr;132(4):371–373. doi: 10.1001/archpedi.1978.02120290043006. [DOI] [PubMed] [Google Scholar]
  99. Nicosia A., Bartoloni A., Perugini M., Rappuoli R. Expression and immunological properties of the five subunits of pertussis toxin. Infect Immun. 1987 Apr;55(4):963–967. doi: 10.1128/iai.55.4.963-967.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Nicosia A., Perugini M., Franzini C., Casagli M. C., Borri M. G., Antoni G., Almoni M., Neri P., Ratti G., Rappuoli R. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4631–4635. doi: 10.1073/pnas.83.13.4631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Oda M., Cowell J. L., Burstyn D. G., Manclark C. R. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis. 1984 Dec;150(6):823–833. doi: 10.1093/infdis/150.6.823. [DOI] [PubMed] [Google Scholar]
  102. Olson L. C. Pertussis. Medicine (Baltimore) 1975 Nov;54(6):427–469. doi: 10.1097/00005792-197511000-00001. [DOI] [PubMed] [Google Scholar]
  103. Onorato I. M., Wassilak S. G. Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J. 1987 Feb;6(2):145–151. doi: 10.1097/00006454-198702000-00002. [DOI] [PubMed] [Google Scholar]
  104. Papasian C. J., Bartholomew W. R., Amsterdam D. Modified enzyme immunoassay for detecting Neisseria gonorrhoeae antigens. J Clin Microbiol. 1984 Oct;20(4):641–643. doi: 10.1128/jcm.20.4.641-643.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Parker C. W., Sullivan T. J., Wedner H. J. Cyclic AMP and the immune response;. Adv Cyclic Nucleotide Res. 1974;4(0):1–79. [PubMed] [Google Scholar]
  106. Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis. 1984 Sep-Oct;3(5):467–486. doi: 10.1097/00006454-198409000-00019. [DOI] [PubMed] [Google Scholar]
  107. Preston N. W., Surapatana N., Carter E. J. A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis. J Hyg (Lond) 1982 Feb;88(1):39–46. doi: 10.1017/s0022172400069874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Regan J., Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol. 1977 Sep;6(3):303–309. doi: 10.1128/jcm.6.3.303-309.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Reiser J., Friedman R. L., Germanier R. Bordetella pertussis filamentous hemagglutinin gene: molecular cloning of a potential coding sequence. Dev Biol Stand. 1985;61:265–271. [PubMed] [Google Scholar]
  110. Robertson P. W., Goldberg H., Jarvie B. H., Smith D. D., Whybin L. R. Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust. 1987 May 18;146(10):522–525. doi: 10.5694/j.1326-5377.1987.tb120392.x. [DOI] [PubMed] [Google Scholar]
  111. Romanus V., Jonsell R., Bergquist S. O. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J. 1987 Apr;6(4):364–371. doi: 10.1097/00006454-198704000-00005. [DOI] [PubMed] [Google Scholar]
  112. Roop R. M., 2nd, Veit H. P., Sinsky R. J., Veit S. P., Hewlett E. L., Kornegay E. T. Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect Immun. 1987 Jan;55(1):217–222. doi: 10.1128/iai.55.1.217-222.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Rosenthal R. S., Nogami W., Cookson B. T., Goldman W. E., Folkening W. J. Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin. Infect Immun. 1987 Sep;55(9):2117–2120. doi: 10.1128/iai.55.9.2117-2120.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Rosenthal R. S. Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities. Infect Immun. 1979 Jun;24(3):869–878. doi: 10.1128/iai.24.3.869-878.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Ross P. W., Cumming C. G. Isolation of Bordetella pertussis from swabs. Br Med J (Clin Res Ed) 1981 Aug 8;283(6288):403–404. doi: 10.1136/bmj.283.6288.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Sato H., Ito A., Chiba J., Sato Y. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun. 1984 Nov;46(2):422–428. doi: 10.1128/iai.46.2.422-428.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Sato H., Sato Y. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect Immun. 1984 Nov;46(2):415–421. doi: 10.1128/iai.46.2.415-421.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Sato Y., Cowell J. L., Sato H., Burstyn D. G., Manclark C. R. Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun. 1983 Jul;41(1):313–320. doi: 10.1128/iai.41.1.313-320.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Sato Y., Izumiya K., Sato H., Cowell J. L., Manclark C. R. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun. 1981 Mar;31(3):1223–1231. doi: 10.1128/iai.31.3.1223-1231.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Sato Y., Kimura M., Fukumi H. Development of a pertussis component vaccine in Japan. Lancet. 1984 Jan 21;1(8369):122–126. doi: 10.1016/s0140-6736(84)90061-8. [DOI] [PubMed] [Google Scholar]
  121. Sekura R. D., Fish F., Manclark C. R., Meade B., Zhang Y. L. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem. 1983 Dec 10;258(23):14647–14651. [PubMed] [Google Scholar]
  122. Selfe S., Hunter D. D., Shattuck R. L., Nathanson N. M., Storm D. R. Alteration of intracellular cAMP levels and beating rates of cultured chick cardiac cells by Bordetella pertussis adenylate cyclase. Mol Pharmacol. 1987 May;31(5):529–534. [PubMed] [Google Scholar]
  123. Shattuck R. L., Oldenburg D. J., Storm D. R. Purification and characterization of a calmodulin-sensitive adenylate cyclase from Bordetella pertussis. Biochemistry. 1985 Nov 5;24(23):6356–6362. doi: 10.1021/bi00344a006. [DOI] [PubMed] [Google Scholar]
  124. Shattuck R. L., Storm D. R. Calmodulin inhibits entry of Bordetella pertussis adenylate cyclase into animal cells. Biochemistry. 1985 Nov 5;24(23):6323–6328. doi: 10.1021/bi00344a001. [DOI] [PubMed] [Google Scholar]
  125. Sinha R. K., Rosenthal R. S. Release of soluble peptidoglycan from growing conococci: demonstration of anhydro-muramyl-containing fragments. Infect Immun. 1980 Sep;29(3):914–925. doi: 10.1128/iai.29.3.914-925.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Sippel J. E., Prato C. M., Girgis N. I., Edwards E. A. Detection of Neisseria meningitidis group A, Haemophilus influenzae type b, and Streptococcus pneumoniae antigens in cerebrospinal fluid specimens by antigen capture enzyme-linked immunosorbent assays. J Clin Microbiol. 1984 Aug;20(2):259–265. doi: 10.1128/jcm.20.2.259-265.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Stauffer L. R., Brown D. R., Sandstrom R. E. Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation of Bordetella pertussis: comparison with previously described media. J Clin Microbiol. 1983 Jan;17(1):60–62. doi: 10.1128/jcm.17.1.60-62.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Steven A. C., Bisher M. E., Trus B. L., Thomas D., Zhang J. M., Cowell J. L. Helical structure of Bordetella pertussis fimbriae. J Bacteriol. 1986 Sep;167(3):968–974. doi: 10.1128/jb.167.3.968-974.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Sutcliffe E. M., Abbott J. D. Selective medium for the isolation of bordetella pertussis and parapertussis. J Clin Pathol. 1972 Aug;25(8):732–733. doi: 10.1136/jcp.25.8.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Tamura M., Nogimori K., Murai S., Yajima M., Ito K., Katada T., Ui M., Ishii S. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry. 1982 Oct 26;21(22):5516–5522. doi: 10.1021/bi00265a021. [DOI] [PubMed] [Google Scholar]
  131. Tamura M., Nogimori K., Yajima M., Ase K., Ui M. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J Biol Chem. 1983 Jun 10;258(11):6756–6761. [PubMed] [Google Scholar]
  132. Tenover F. C. Diagnostic deoxyribonucleic acid probes for infectious diseases. Clin Microbiol Rev. 1988 Jan;1(1):82–101. doi: 10.1128/cmr.1.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Tilton R. C., Dias F., Ryan R. W. Comparative evaluation of three commercial products and counterimmunoelectrophoresis for the detection of antigens in cerebrospinal fluid. J Clin Microbiol. 1984 Aug;20(2):231–234. doi: 10.1128/jcm.20.2.231-234.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Totten P. A., Holmes K. K., Handsfield H. H., Knapp J. S., Perine P. L., Falkow S. DNA hybridization technique for the detection of Neisseria gonorrhoeae in men with urethritis. J Infect Dis. 1983 Sep;148(3):462–471. doi: 10.1093/infdis/148.3.462. [DOI] [PubMed] [Google Scholar]
  135. Tuomanen E. I., Zapiain L. A., Galvan P., Hewlett E. L. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J Clin Microbiol. 1984 Aug;20(2):167–170. doi: 10.1128/jcm.20.2.167-170.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Tuomanen E., Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis. 1985 Jul;152(1):118–125. doi: 10.1093/infdis/152.1.118. [DOI] [PubMed] [Google Scholar]
  137. Urisu A., Cowell J. L., Manclark C. R. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun. 1986 Jun;52(3):695–701. doi: 10.1128/iai.52.3.695-701.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Utsumi S., Sonoda S., Imagawa T., Kanoh M. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities. Biken J. 1978 Dec;21(4):121–135. [PubMed] [Google Scholar]
  139. Viljanen M. K., Ruuskanen O., Granberg C., Salmi T. T. Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis. 1982;14(2):117–122. doi: 10.3109/inf.1982.14.issue-2.08. [DOI] [PubMed] [Google Scholar]
  140. WHITAKER J. A., DONALDSON P., NELSON J. D. Diagnosis of pertussis by the fluorescent-antibody method. N Engl J Med. 1960 Oct 27;263:850–851. doi: 10.1056/NEJM196010272631708. [DOI] [PubMed] [Google Scholar]
  141. WILSON A. T., HENDERSON I. R., MOORE E. J., HEYWOOD S. N. WHOOPING-COUGH: DIFFICULTIES IN DIAGNOSIS AND INEFFECTIVENESS OF IMMUNIZATION. Br Med J. 1965 Sep 11;2(5462):623–626. doi: 10.1136/bmj.2.5462.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Walsh J. A., Warren K. S. Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med. 1979 Nov 1;301(18):967–974. doi: 10.1056/NEJM197911013011804. [DOI] [PubMed] [Google Scholar]
  143. Wardlaw A. C., Parton R. Bordetella pertussis toxins. Pharmacol Ther. 1982;19(1):1–53. doi: 10.1016/0163-7258(82)90041-9. [DOI] [PubMed] [Google Scholar]
  144. Weiss A. A., Hewlett E. L., Myers G. A., Falkow S. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis. 1984 Aug;150(2):219–222. doi: 10.1093/infdis/150.2.219. [DOI] [PubMed] [Google Scholar]
  145. Weiss A. A., Hewlett E. L., Myers G. A., Falkow S. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun. 1983 Oct;42(1):33–41. doi: 10.1128/iai.42.1.33-41.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Weiss A. A., Hewlett E. L. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. doi: 10.1146/annurev.mi.40.100186.003305. [DOI] [PubMed] [Google Scholar]
  147. Wilkins J., Williams F. F., Wehrle P. F., Portnoy B. Agglutinin response to pertussis vaccine. I. Effect of dosage and interval. J Pediatr. 1971 Aug;79(2):197–202. doi: 10.1016/s0022-3476(71)80101-4. [DOI] [PubMed] [Google Scholar]
  148. Winters A. L., Baggett D. W., Lee J. D., Sloan G. L., Lemmon R. D., Stinson R. S. Immunomodulation by Bordetella pertussis: antiviral effects. Dev Biol Stand. 1985;61:233–240. [PubMed] [Google Scholar]
  149. Wolff J., Cook G. H. Activation of thyroid membrane adenylate cyclase by purine nucleotides. J Biol Chem. 1973 Jan 10;248(1):350–355. [PubMed] [Google Scholar]
  150. Wolff J., Cook G. H., Goldhammer A. R., Berkowitz S. A. Calmodulin activates prokaryotic adenylate cyclase. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3841–3844. doi: 10.1073/pnas.77.7.3841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Yolken R. H. Enzyme immunoassays for the detection of infectious antigens in body fluids: current limitations and future prospects. Rev Infect Dis. 1982 Jan-Feb;4(1):35–68. doi: 10.1093/clinids/4.1.35. [DOI] [PubMed] [Google Scholar]
  152. Zhang J. M., Cowell J. L., Steven A. C., Carter P. H., McGrath P. P., Manclark C. R. Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun. 1985 May;48(2):422–427. doi: 10.1128/iai.48.2.422-427.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Zhang J. M., Cowell J. L., Steven A. C., Manclark C. R. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand. 1985;61:173–185. [PubMed] [Google Scholar]
  154. Zoumboulakis D., Anagnostakis D., Albanis V., Matsaniotis N. Steroids in treatment of pertussis. A controlled clinical trial. Arch Dis Child. 1973 Jan;48(1):51–54. doi: 10.1136/adc.48.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES